MSFinals-2938

A 47-year-old woman visits the renal clinic after six weeks of a triumphant renal transplant. She has some inquiries about her immunosuppression for the consultant. The doctor clarifies that the typical regimen for renal transplant patients involves the initial utilization of an induction agent, followed by a combination of a calcineurin inhibitor, antimetabolite, and steroids. This combination is intended to prevent rejection of the transplanted kidney. What is the name of the anti-lymphocyte monoclonal antibody used as an induction agent?